Sionna Therapeutics, Inc.
NASDAQ:SIONBiotechnology
+$0.68 today
- Market cap
- $134.35M
- Beta
- 1.29
- P/E (TTM)
- -19.7
- EPS (TTM)
- -$1.90
Volume 0.52M
Average 0.39M
SION Debt Repayment
Cash used to repay borrowings during the period.
Sionna Therapeutics, Inc.NASDAQ: SION
Debt Repayment · Q1 FY2026 · quarter ended Mar 2026
Debt repayment outflow grows to $0
Q1 FY2026 debt repayment was $0, compared with $0 a year earlier. Trailing-twelve-month debt repayment was $0.
Context
- Debt repayment increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly debt repayment holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Debt Repayment history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Debt Repayment | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
Debt Repayment vs competitors
How SION compares with its peers on the latest reported figures
- SION's LTM Mar 2026 debt repayment of $0 is the 6th largest of the 11 companies compared; the peer median is $4.58M.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $592.11M | +29605750.0% | — | 222.6% | |
| LTM Mar 2026 | $48.67M | -0.1% | — | 11.4% | |
| LTM Mar 2026 | $38.52M | +342.0% | — | 192.6% | |
| LTM Sep 2026 | $17.72M | -29.4% | — | 26.1% | |
| LTM Mar 2026 | $9.17M | — | -55.3% | 2.9% | |
| LTM Mar 2026 | $0 | — | — | — | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | — | |
| LTM Jun 2026 | $0 | — | -17.7% | — | |
| LTM Jun 2026 | $0 | — | +5.6% | — | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding SION) | $4.58M | +171.0% | -17.7% | 11.4% | |
Competitors are the stored peer set for SION. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Sionna Therapeutics, Inc.
NASDAQ:SION
Intrinsic Alpha fair value
Locked
Current Price
$2.97
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.